Related Experiment Video
Updated: Aug 6, 2026

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
Protocol for detecting causal variants by co-localizing GWAS and QTL studies using colocRedRibbon
Theodora Papadopoulou1, Aristeidis Sionakidis2, Anthony Piron3
1ULB Center for Diabetes Research, Medical Faculty, Université Libre de Bruxelles, 1070 Brussels, Belgium; Interuniversity Institute of Bioinformatics in Brussels (IB2), 1050 Brussels, Belgium.
This study introduces colocRedRibbon, a method to link genetic variants associated with diseases to changes in gene expression. It helps identify potential therapeutic targets by analyzing genome-wide association study (GWAS) single nucleotide polymorphisms (SNPs) alongside cis-expression quantitative trait loci (eQTLs).
Area of Science:
- Genetics
- Genomics
- Bioinformatics
Background:
- Genome-wide association studies (GWAS) identify genetic variants linked to diseases.
- Expression quantitative trait loci (eQTLs) reveal genetic influences on gene expression.
- Linking these datasets is crucial for understanding disease mechanisms.
Purpose of the Study:
- To present a protocol for co-localizing GWAS SNPs with cis-eQTLs using colocRedRibbon.
- To enable the identification of disease-associated variants influencing gene expression.
- To provide a framework for discovering potential therapeutic targets.
Main Methods:
- Development of the colocRedRibbon protocol.
- Shortlisting relevant GWAS and eQTL variants.
- Computation of co-localization statistics and posterior probabilities.
Main Results:
- The protocol effectively co-localizes GWAS SNPs with cis-eQTLs.
- Co-localized variants offer insights into disease-related gene expression changes.
- Demonstrated applicability to diverse QTL types and GWAS datasets.
Conclusions:
- The colocRedRibbon protocol facilitates the integration of GWAS and eQTL data.
- This integration aids in understanding genetic contributions to disease.
- The method supports the identification of novel therapeutic targets.
More Related Videos
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
05:53Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Single Nucleotide Polymorphisms-SNPs
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...